G0433 HCPCS Level II code: Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
G0433 is the HCPCS code for “Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G0433Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
Short description: Elisa hiv-1/hiv-2 screen
HCPCS · United States
Notes for G0433
As CMS prints them, with any note G0433 takes from the headings above it.
Note
- CMS processing note 0164: SEE CHANGE REQUEST 6786.
Medicare details
The indicators CMS publishes with G0433 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Clinical lab fee schedule – Price subject to national limitation amount
- Type of service
- Other medical items or services
- BETOS category
- Lab tests - other (Non-Medicare fee schedule)
- Lab certification
- Virology; General immunology
- Added
- Dec 8, 2009
Where G0433 sits
- 1G codesProcedures and professional services
- 2Active code G0433Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G0433 mean?
G0433 is the HCPCS code for “Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G0433?
CMS lists G0433’s Medicare coverage as “Carrier judgment” and its pricing as “Clinical lab fee schedule – Price subject to national limitation amount”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G0433
All G codesG0426Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealthG0427Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealthG0428Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)G0429Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)G0431Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounterG0432Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screeningG0434Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounterG0435Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screeningG0436Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutesG0437Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutesG0438Annual wellness visit; includes a personalized prevention plan of service (pps), initial visitG0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit